Presenters at ADCES (pictured above, from left to right): Beverly Thomassian, RN, MPH, CDCES, BC-ADM Sarah Hormachea, MS, RD, CDCES, BC-ADM Russ Powell, MS, RD, CDCES, BC-ADM Vivian Ayuk, PharmD, … Continue reading What We Wish We Knew: Lessons from Diabetes Entrepreneurs | ADCES Conference Panelist 2026
A 36-year-old has an A1C of 6.2%, BMI of 36, hypertension, and a strong family history of type 2 diabetes. Despite sustained nutrition and physical activity interventions, they can’t seem … Continue reading Test Your Knowledge Tuesday | Does AACE recommend meds to treat prediabetes?
Mid-Month e-News I’m getting to the age when people occasionally ask me, “So, how much longer are you going to work?” Ouch. I pat down my ruffled feathers, smile, and … Continue reading September 2026 Mid-Month e-News | Keep Working & Scooping Ice Cream
For last week’s practice question, we quizzed participants on which response BEST supports sustainable medication-taking. 77% of respondents chose the best answer. We want to clarify and share this important information, … Continue reading What’s The Best Answer Thursday | Which response BEST supports sustainable medication-taking?
Register for FREE September 30th Webcast Author: Marie Frazzitta DNP, FNP-c, PMHNP, CDCES, MBA Did you know that YOU are practicing in a healthcare system where the traditional fee for … Continue reading How Digital Quality Measures Are Shaping Value-Based Diabetes Care
CJ is living with type 1 diabetes and calls the diabetes-education clinic, recently learning she is 7-weeks gestation. CJ uses a hybrid closed-loop (automated insulin delivery or AID) insulin pump … Continue reading Test Your Knowledge Tuesday | Modifications needed for diabetes therapy plan? Best response?
For last week’s practice question, we quizzed participants on how glycemic control can be documented. 37% of respondents chose the best answer. We want to clarify and share this important … Continue reading What’s The Best Answer Thursday | A1C unavailable, but GMI is 7.2%. How can glycemic control be documented?
Author: Beverly Thomassian, RN, MPH, CDCES, BC-ADM CEO: DiabetesEd Services The landscape of metabolic monitoring has fundamentally shifted; the U.S. FDA authorizes the first Continuous Glucose-Ketone Monitor. The Libre Duo … Continue reading A New Paradigm in Diabetes Care: FDA Authorizes the World’s First Continuous Glucose-Ketone Monitor